Marta Garzón-Benavides

Marta Garzón-Benavides

Auto-generated profile, based on publicly available information

Marta Garzón-Benavides

Hospital Universitario Virgen del Rocío

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
ÁCÁngela Ruiz Carnicer
Ángela Ruiz Carnicer
MGMarta Garzón-Benavides
Marta Garzón-Benavides
BFBlanca Fombuena
Blanca Fombuena
VMVERÓNICA MONTERO
VERÓNICA MONTERO
FGFrancisco García-Fernández
Francisco García-Fernández
ÁPÁngeles Pizarro
Ángeles Pizarro
The treatment of celiac disease (CD) is a lifelong gluten-free diet (GFD). The current methods for monitoring GFD conformance, such as a dietary questionnaire or serology tests, may be inaccurate in detecting dietary transgressions, and duodenal biopsies are invasive, expensive, and not a routine monitoring technique. Our aim was to determine the clinical usefulness of urine gluten immunogenic peptides (GIP) as a biomarker monitoring GFD adherence in celiac patients and to evaluate the concordance of the results with the degree of mucosal damage. A prospective observational study was conducted involving 22 de novo CD patients, 77 celiac patients consuming a GFD, and 13 nonceliac subjects. On 3 d of the week, urine samples were collected and the GIP concentrations were tested. Simultaneously, anti-tissue transglutaminase antibodies, questionnaire results, clinical manifestations, and histological findings were analyzed. Approximately 24% (18 of 76) of the celiac patients consuming a GFD exhibited Marsh II-III mucosal damage. Among this population, 94% (17 of 18) had detectable urine GIP; however, between 60% and 80% were asymptomatic and exhibited negative serology and appropriate GFD adherence based on the questionnaire. In contrast, 97% (31 of 32) of the celiac patients without duodenal damage had no detectable GIP. These results demonstrated the high sensitivity (94%) and negative predictive value (97%) of GIP measurements in relation to duodenal biopsy findings. In the de novo CD-diagnosed cohort, 82% (18 of 22) of patients had measurable amounts of GIP in the urine. Determining GIP concentrations in several urine samples may be an especially convenient approach to assess recent gluten exposure in celiac patients and appears to accurately predict the absence of histological lesions. The introduction of GIP testing as an assessment technique for GFD adherence may help in ascertaining dietary compliance and to target the most suitable intervention during follow-up.

1 October 2009 in European Journal of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
CCCarmen Cordero-Fernández
Carmen Cordero-Fernández
MGMarta Garzón-Benavides
Marta Garzón-Benavides
APAngeles Pizarro-Moreno
Angeles Pizarro-Moreno
RGRaul García-Lozano
Raul García-Lozano
JMJose Luis Márquez-Galán
Jose Luis Márquez-Galán
OLOvidio Belda Laguna
Ovidio Belda Laguna
Analysis of the incidence rate and the evolution of duodenal and stomach polyps in our familial adenomatous polyposis (FAP) patients, the suitability of the surveillance method and the cancer-preventing treatment applied and the analysis of the complications arising from each procedure employed. Twenty-nine patients diagnosed with FAP underwent study and endoscopic surveillance of the upper digestive tract. Front-view and side-view endoscopies were used. Papillary biopsies were performed even when the papilla were macroscopically normal. The Spigelman classification was used to determine the seriousness of the condition and to establish the surveillance and treatment intervals. Duodenal and/or papillary polyps were presented by 79.3% of the patients. Endoscopic polypectomy was performed in 13 patients with duodenal polyps. Endoscopic polypectomies for the papilla were performed in all patients. One patient required a cephalic duodenopancreatectomy and another endoscopic ampullectomy. The condition did not become cancerous in any of the patients who underwent surveillance. We report two complications arising from treatment: one postpolypectomy haemorrhage and one stenosis of the biliary-enteric anastomosis after cephalic duodenopancreatectomy. Our study shows a high incidence rate of duodenal polyps in FAP patients. A minute examination of the duodenum and papilla is necessary, using side-view endoscopes and duodenal papilla biopsies even when papilla appears to be normal. None of the patients having completed the surveillance and the prescribed treatment developed cancer and all have a low Spigelman score. This method, therefore, seems to be adequate for the treatment and surveillance of duodenal polyps.

1 February 2020 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
MPMaría Dolores Picó
María Dolores Picó
ACAdela Castillejo
Adela Castillejo
OMOscar Murcia
Oscar Murcia
MGMar Giner-Calabuig
Mar Giner-Calabuig
MAMiren Alustiza
Miren Alustiza
Rodrigo JoverRodrigo Jover
Rodrigo Jover

8 March 2023 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
MGMarta Garzón‐Benavides
Marta Garzón‐Benavides
ÁRÁngela Ruiz‐Carnicer
Ángela Ruiz‐Carnicer
VSVerónica Segura
Verónica Segura
BFBlanca Fombuena
Blanca Fombuena
FGFrancisco García‐Fernandez
Francisco García‐Fernandez
ÁPÁngeles Pizarro‐Moreno
Ángeles Pizarro‐Moreno
Summary: Background: Gluten‐free diet (GFD) is the only treatment for patients with coeliac disease (CD)and its compliance should be monitored to avoid cumulative damage.Aims: To analyse gluten exposures of coeliac patients on GFD for at least 24 months using different monitoring tools and its impact on duodenal histology at 12‐month follow‐up and evaluate the interval of determination of urinary gluten immunogenic peptides (u‐GIP) for the monitoring of GFD adherence.Methods: Ninety‐four patients with CD on a GFD for at least 24 months were prospectively included. Symptoms, serology, CDAT questionnaire, and u‐GIP (three samples/visit) were analysed at inclusion, 3, 6, and 12 months. Duodenal biopsy was performed at inclusion and 12 months.Results: At inclusion, 25.8% presented duodenal mucosal damage; at 12 months, this percentage reduced by half. This histological improvement was indicated by a reduction in u‐GIP but did not correlate with the remaining tools. The determination of u‐GIP detected a higher number of transgressions than serology, regardless of histological evolution type. The presence of >4 u‐GIP‐positive samples out of 12 collected during 12 months predicted histological lesion with a specificity of 93%. Most patients (94%) with negative u‐GIP in ≥2 follow‐up visits showed the absence of histological lesions (p < 0.05).Conclusion: This study suggests that the frequency of recurrent gluten exposures, according to serial determination of u‐GIP, could be related to the persistence of villous atrophy and that a more regular follow‐up every 6 months, instead of annually, provides more useful data about the adequate adherence to GFD and mucosal healing.

1 December 2009 in Revista Española de Enfermedades Digestivas
Verified
Journal Article
Open access
PDF file
APA. Pizarro-Moreno
A. Pizarro-Moreno
CCC. Cordero-Fernández
C. Cordero-Fernández
MGM. Garzón-Benavides
M. Garzón-Benavides
ACAurelio Cayuela
Aurelio Cayuela
JBJ. M. Bozada-García
J. M. Bozada-García
JMJ. L. Márquez-Galán
J. L. Márquez-Galán
A) to evaluate the appropriateness of histological criteria as proposed by Morson as indicators for surgery; and b) to compare the adequacy of Morson s criteria with Haggitt s levels as indicators for surgery in the case of malignant sessile lesions. we carried out a prospective, protocolized study of 42 patients with polyps with invasive carcinoma (IC) who underwent colonoscopic polypectomy from 1979 through 2008. We applied the histological criteria proposed by Morson to all the patients included in the series. we treated 24 polyps with IC and favorable histological criteria (FC) and 18 polyps showing unfavorable histological criteria (UC). All polyps with FC were treated by means of colonoscopic polypectomy. None of the patients showed signs of disease after a mean follow-up period o f 9.67 yrs. Patients with polyps with UC were recommended to undergo surgery. The presence of unfavorable histological criteria in the polypectomy sample was clearly associated with an unfavorable patient outcome and showed a 100% sensitivity level, a negative prognostic value (NPV) of 100%, and a false negative (FN) percentage of 0% for the prognosis of the disease. We found 12 sessile polyps (Haggitt s level 4). Colonoscopic polypectomy was the treatment employed in 9 out of 12 cases. All patients are free from disease (mean follow-up 7.3 yrs). If Haggitt s level criteria had been applied, all 12 patients would have undergone surgery. This means 58% more patients than following Morson s criteria. Morson s criteria are considered an adequate diagnostic tool for the indication of surgery in patients with malignant adenomas. Haggitt s invasion levels do not accurately discriminate the necessity for surgery in case of malignant sessile lesions.

1 November 2010 in Revista Española de Enfermedades Digestivas
Verified
Journal Article
Open access
PDF file
MBM. Garzón Benavides
M. Garzón Benavides
AMA. Pizarro Moreno
A. Pizarro Moreno
RLR. García Lozano
R. García Lozano
MGM. I. Herrero Garrido
M. I. Herrero Garrido
AMA. J. Hervás Molina
A. J. Hervás Molina
CFC. Cordero Fernandez
C. Cordero Fernandez
To evaluate the phenotype and genotype characteristic of patients included in the Andalusian Registry for familial adenomatous polyposis, the genotype/phenotype correlation and the impact of Registry in the frequency of colorectal cancer of registered.